OXYRANE Overview
Company Headquarters: Manchester, UK
Founded: 2006
Company Working: Oxyrane is a biopharmaceutical company involved in developing innovative enzyme replacement therapies for the treatment of lysosomal storage diseases. The company delivers human lysosomal enzymes that permit clinically useful enzyme uptake and localization using its glycoengineered yeast platform. The company operates in Belgium, Burlington, and Massachusetts.



